A four-stage strategy to reduce childhood pneumonia-related mortality by 2015 and beyond

Vaccine

Volumn 27, Issue 5, 2009, Pages 619-623

  Brooks, W Abdullah ^a  

^a ICDDRB Division of Health Systems and Infectious Diseases   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE;

CHILD; CHILDHOOD MORTALITY; COST BENEFIT ANALYSIS; DRUG COST; EDITORIAL; HEALTH CARE PLANNING; HEALTH PROGRAM; HUMAN; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; PNEUMONIA; PRIORITY JOURNAL; RISK REDUCTION;

AFRICA; ASIA; CHILD, PRESCHOOL; HUMANS; INFANT; INFLUENZA VACCINES; PNEUMOCOCCAL VACCINES; PNEUMONIA;

EID: 58249111563     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.10.071     Document Type: Editorial

References (59)

1. Bryce J., Boschi-Pinto C., Shibuya K., and Black R.E. WHO estimates of the causes of death in children. Lancet 365 April (9465) (2005) 1147-1152
2. United Nations. UN millennium development goals; 2008 [cited 2008, 19 April 2008]. Available from: http://www.un.org/millenniumgoals/index.html.
3. UNICEF/WHO. Pneumonia: the forgotten killer of children. New York, Geneva: The United Nations Children's Fund (UNICEF)/World Health Organization (WHO); 2006.
4. Scott J.A., Brooks W.A., Peiris J.S., Holtzman D., and Mulhollan E.K. Pneumonia research to reduce childhood mortality in the developing world. J Clin Invest 118 April (4) (2008) 1291-1300
5. Rudan I., Boschi-Pinto C., Biloglav Z., Mulholland K., and Campbell H. Epidemiology and etiology of childhood pneumonia. Bull World Health Organ 86 May (5) (2008) 408-416
6. Levine O.S., O'Brien K.L., Knoll M., Adegbola R.A., Black S., Cherian T., et al. Pneumococcal vaccination in developing countries. Lancet 367 June (9526) (2006) 1880-1882
7. Mulholland K. Childhood pneumonia mortality-a permanent global emergency. Lancet 370 July (9583) (2007) 285-289
8. Madhi S.A., Levine O.S., Hajjeh R., Mansoor O.D., and Cherian T. Vaccines to prevent pneumonia and improve child survival. Bull World Health Org 86 May (5) (2008) 365-372
9. Brooks W.A., Breiman R.F., Goswami D., Hossain A., Alam K., Saha S.K., et al. Invasive pneumococcal disease burden and implications for vaccine policy in urban Bangladesh. Am J Trop Med Hyg 77 November (5) (2007) 795-801
10. Kallenberg J. Expanding GAVI'svaccine portfolio. Paris, France: WHO Global Vaccine Research Forum; 2008.
11. Viboud C., Alonso W.J., and Simonsen L. Influenza in tropical regions. PLoS Med 3 April (4) (2006) e89
12. Monto A.S., and Kioumehr F. The Tecumseh Study of respiratory illness. IX. Occurrence of influenza in the community, 1966-1971. Am J Epidemiol 102 December (6) (1975) 553-563
13. Heikkinen T., Silvennoinen H., Peltola V., Ziegler T., Vainionpaa R., Vuorinen T., et al. Burden of influenza in children in the community. J Infect Dis 190 October (8) (2004) 1369-1373
14. Neuzil K.M., Zhu Y., Griffin M.R., Edwards K.M., Thompson J.M., Tollefson S.J., et al. Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. J Infect Dis 185 January (2) (2002) 147-152
15. Nicholson K.G., Wood J.M., and Zambon M. Influenza. Lancet 362 November (9397) (2003) 1733-1745
16. Aymard M., Valette M., and Luciani J. Burden of influenza in children: preliminary data from a pilot survey network on community diseases. Pediatr Infect Dis J 22 October (10 Suppl.) (2003) S211-S214
17. Henrickson K.J., Hoover S., Kehl K.S., and Hua W. National disease burden of respiratory viruses detected in children by polymerase chain reaction. Pediatr Infect Dis J 23 January (1 Suppl.) (2004) S11-S18
18. Poehling K.A., Edwards K.M., Weinberg G.A., Szilagyi P., Staat M.A., Iwane M.K., et al. The underrecognized burden of influenza in young children. N Engl J Med 355 July (1) (2006) 31-40
19. Izurieta H.S., Thompson W.W., Kramarz P., Shay D.K., Davis R.L., DeStefano F., et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 342 January (4) (2000) 232-239
20. Neuzil K.M., Mellen B.G., Wright P.F., Mitchel Jr. E.F., and Griffin M.R. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 342 January (4) (2000) 225-231
21. Donatelli I., and Pregliasco F. WHO influenza global agenda. Ann Ist Super Sanita 39 3 (2003) 425-433
22. World Health Organisation. Influenza vaccines. WHO position paper. Wkly Epidemiol Rec 80 August (33) (2005) 279-287
23. Wong C.M., Yang L., Chan K.P., Leung G.M., Chan K.H., Guan Y., et al. Influenza-associated hospitalization in a subtropical city. PLoS Med 3 April (4) (2006) e121
24. International Centre for Diarrhoeal Disease Research. Population-based influenza surveillance, Dhaka. Health Sci Bull 2006;4(1):1-5.
25. McCullers J.A., and Bartmess K.C. Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae. J Infect Dis 187 March (6) (2003) 1000-1009
26. O'Brien K.L., Walters M.I., Sellman J., Quinlisk P., Regnery H., Schwartz B., et al. Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection. Clin Infect Dis 30 May (5) (2000) 784-789
27. Talbot T.R., Poehling K.A., Hartert T.V., Arbogast P.G., Halasa N.B., Edwards K.M., et al. Seasonality of invasive pneumococcal disease: temporal relation to documented influenza and respiratory syncytial viral circulation. Am J Med 118 March (3) (2005) 285-291
28. Toschke A.M., Arenz S., von Kries R., Puppe W., Weigl J.A., Hohle M., et al. No temporal association between influenza outbreaks and invasive pneumococcal infections. Arch Dis Child 93 March (3) (2008) 218-220
29. Brent A.J., Ahmed I., Ndiritu M., Lewa P., Ngetsa C., Lowe B., et al. Incidence of clinically significant bacteraemia in children who present to hospital in Kenya: community-based observational study. Lancet 367 February (9509) (2006) 482-488
30. Cutts F.T., Zaman S.M., Enwere G., Jaffar S., Levine O.S., Okoko J.B., et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 365 March-April (9465) (2005) 1139-1146
31. Michelow I.C., Olsen K., Lozano J., Rollins N.K., Duffy L.B., Ziegler T., et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics 113 April (4) (2004) 701-707
32. Madhi S.A., and Klugman K.P. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med 10 August (8) (2004) 811-813
33. Klugman K.P., and Madhi S.A. Pneumococcal vaccines and flu preparedness. Science 316 April (5821) (2007) 49-50
34. McCullers J.A. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev 19 July (3) (2006) 571-582
35. Walter E.B., Neuzil K.M., Zhu Y., Fairchok M.P., Gagliano M.E., Monto A.S., et al. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?. Pediatrics 118 September (3) (2006) e570-e578
36. Fiore A.E., Shay D.K., Haber P., Iskander J.K., Uyeki T.M., Mootrey G., et al. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 56 July (RR-6) (2007) 1-54
37. Smith S., Demicheli V., Di Pietrantonj C., Harnden A.R., Jefferson T., Matheson N.J., et al. Vaccines for preventing influenza in healthy children. Cochrane Database System Rev January (1) (2006) CD004879
38. Zangwill K.M., and Belshe R.B. Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccination. Pediatr Infect Dis J 23 March (3) (2004) 189-197
39. Jefferson T., Smith S., Demicheli V., Harnden A., Rivetti A., and Di Pietrantonj C. Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review. Lancet 365 February-March (9461) (2005) 773-780
40. Manzoli L., Schioppa F., Boccia A., and Villari P. The efficacy of influenza vaccine for healthy children: a meta-analysis evaluating potential sources of variation in efficacy estimates including study quality. Pediatr Infect Dis J 26 February (2) (2007) 97-106
41. Jefferson T.O., Rivetti D., Di Pietrantonj C., Rivetti A., and Demicheli V. Vaccines for preventing influenza in healthy adults. Cochrane Database System Rev 2 (2007) CD001269
42. Negri E., Colombo C., Giordano L., Groth N., Apolone G., and La Vecchia C. Influenza vaccine in healthy children: a meta-analysis. Vaccine 23 April (22) (2005) 2851-2861
43. Belshe R.B., Gruber W.C., Mendelman P.M., Cho I., Reisinger K., Block S.L., et al. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr 136 February (2) (2000) 168-175
44. Mendelman P.M., Rappaport R., Cho I., Block S., Gruber W., August M., et al. Live attenuated influenza vaccine induces cross-reactive antibody responses in children against an a/Fujian/411/2002-like H3N2 antigenic variant strain. Pediatr Infect Dis J 23 November (11) (2004) 1053-1055
45. Hausdorff W.P., Bryant J., Paradiso P.R., and Siber G.R. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis 30 January (1) (2000) 100-121
46. World Health Organisation. Pneumococcal conjugate vaccine for childhood immunization-WHO position paper. Wkly Epidemiol Rec 82 March (12) (2007) 93-104
47. Zaman K., Roy E., Arifeen S.E., Rahman M., Raqib R., Wilson E., et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 359 October (15) (2008) 1555-1564
48. World Health Organisation. 23-valent pneumococcal polysaccharide vaccine. WHO position paper. Wkly Epidemiol Rec 83 42 (2008) 373-384
49. Center K.J. Prevenar vaccination: review of the global data, 2006. Vaccine 25 April (16) (2007) 3085-3089
50. Chiu S.S., Lau Y.L., Chan K.H., Wong W.H., and Peiris J.S. Influenza-related hospitalizations among children in Hong Kong. N Engl J Med 347 December (26) (2002) 2097-2103
51. Barrett D.J. Human immune responses to polysaccharide antigens: an analysis of bacterial polysaccharide vaccines in infants. Adv Pediatrics 32 (1985) 139-158
52. Lee W.M., Grindle K., Pappas T., Marshall D.J., Moser M.J., Beaty E.L., et al. High-throughput, sensitive, and accurate multiplex PCR-microsphere flow cytometry system for large-scale comprehensive detection of respiratory viruses. J Clin Microbiol 45 August (8) (2007) 2626-2634
53. Garcia A., Roson B., Perez J.L., Verdaguer R., Dorca J., Carratala J., et al. Usefulness of PCR and antigen latex agglutination test with samples obtained by transthoracic needle aspiration for diagnosis of pneumococcal pneumonia. J Clin Microbiol 37 March (3) (1999) 709-714
54. Coiras M.T., Aguilar J.C., Garcia M.L., Casas I., and Perez-Brena P. Simultaneous detection of fourteen respiratory viruses in clinical specimens by two multiplex reverse transcription nested-PCR assays. J Med Virol 72 March (3) (2004) 484-495
55. Grondahl B., Puppe W., Hoppe A., Kuhne I., Weigl J.A., and Schmitt H.J. Rapid identification of nine microorganisms causing acute respiratory tract infections by single-tube multiplex reverse transcription-PCR: feasibility study. J Clin Microbiol 37 January (1) (1999) 1-7
56. UNICEF/WHO. WHO/UNICEF joint statement: clinical management of acute diarrhoea. The United Nations Childrens Fund/World Health Organization; 2004. p. 1-8.
57. Jacobs M.R. Worldwide trends in antimicrobial resistance among common respiratory tract pathogens in children. Pediatr Infect Dis J 22 August (8 Suppl.) (2003) S109-S119
58. Rameix-Welti M.A., Enouf V., Cuvelier F., Jeannin P., and van der Werf S. Enzymatic properties of the neuraminidase of seasonal H1N1 influenza viruses provide insights for the emergence of natural resistance to oseltamivir. PLoS Pathogens 4 July (7) (2008) e1000103
59. Klugman K.P., Madhi S.A., Huebner R.E., Kohberger R., Mbelle N., and Pierce N. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 349 October (14) (2003) 1341-1348